Benzinga

Benzinga

Benzinga

lundi, août 24

BridgeBio Pharma Inc

BBIONASDAQ
Trade with Public
Trade with Public
$81.50
-1.44-1.74%
À la clôture: Aug 21, 5:00 PM EST
$81.50
N/A
Après les heures: Aug 21, 4:00 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

BridgeBio Pharma Financials

BridgeBio Pharma (BBIO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
BridgeBio Pharma Q2 EPS $(0.78) Misses $(0.59) Estimate, Sales $243.676M Beat $218.743M Estimate

BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.59) by 32.2 percent. This is a 17.89 percent increase over losses of $(0.95) per share
Benzinga Newsdesk

PRO
BridgeBio Pharma Q1 EPS $(0.84) Misses $(0.67) Estimate, Sales $194.515M Beat $177.937M Estimate

BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.67) by 25.37 percent. This is a 4.55 percent increase over losses of $(0.88) per share from
Benzinga Newsdesk

BridgeBio Pharma Earnings Review: Q4 Summary

Benzinga Insights

PRO
BridgeBio Pharma Q4 EPS $(1.00) Misses $(0.66) Estimate, Sales $154.178M Beat $146.844M Estimate

BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(1.00) per share which missed the analyst consensus estimate of $(0.66) by 52.67 percent. This is a 28.57 percent increase over losses of $(1.40) per share
Benzinga Newsdesk

Earnings Scheduled For February 24, 2026

Benzinga Insights

Insights Ahead: BridgeBio Pharma's Quarterly Earnings

Benzinga Insights

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved